Hopwood JJ - Search Results

1

Stop-codon read-through for patients affected by a lysosomal storage disorder.

Brooks DA, Muller VJ, Hopwood JJ. Brooks DA, et al. Among authors: hopwood jj. Trends Mol Med. 2006 Aug;12(8):367-73. doi: 10.1016/j.molmed.2006.06.001. Epub 2006 Jun 23. Trends Mol Med. 2006. PMID: 16798086 Review.

2

alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.

Hein LK, Bawden M, Muller VJ, Sillence D, Hopwood JJ, Brooks DA. Hein LK, et al. Among authors: hopwood jj. J Mol Biol. 2004 Apr 30;338(3):453-62. doi: 10.1016/j.jmb.2004.03.012. J Mol Biol. 2004. PMID: 15081804

3

Immunochemistry of lysosomal storage disorders.

Parkinson-Lawrence E, Fuller M, Hopwood JJ, Meikle PJ, Brooks DA. Parkinson-Lawrence E, et al. Among authors: hopwood jj. Clin Chem. 2006 Sep;52(9):1660-8. doi: 10.1373/clinchem.2005.064915. Epub 2006 Jul 13. Clin Chem. 2006. PMID: 16840586 Review.

4

Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder.

Brooks DA, Kakavanos R, Hopwood JJ. Brooks DA, et al. Among authors: hopwood jj. Trends Mol Med. 2003 Oct;9(10):450-3. doi: 10.1016/j.molmed.2003.08.004. Trends Mol Med. 2003. PMID: 14557058 Review.

5

Lysosomal biogenesis in lysosomal storage disorders.

Karageorgos LE, Isaac EL, Brooks DA, Ravenscroft EM, Davey R, Hopwood JJ, Meikle PJ. Karageorgos LE, et al. Among authors: hopwood jj. Exp Cell Res. 1997 Jul 10;234(1):85-97. doi: 10.1006/excr.1997.3581. Exp Cell Res. 1997. PMID: 9223373

6

Newborn screening for lysosomal storage disorders.

Meikle PJ, Ranieri E, Ravenscroft EM, Hua CT, Brooks DA, Hopwood JJ. Meikle PJ, et al. Among authors: hopwood jj. Southeast Asian J Trop Med Public Health. 1999;30 Suppl 2:104-10. Southeast Asian J Trop Med Public Health. 1999. PMID: 11400743

7

Iduronate-2-sulphatase protein detection in plasma from mucopolysaccharidosis type II patients.

Parkinson EJ, Muller V, Hopwood JJ, Brooks DA. Parkinson EJ, et al. Among authors: hopwood jj. Mol Genet Metab. 2004 Jan;81(1):58-64. doi: 10.1016/j.ymgme.2003.11.002. Mol Genet Metab. 2004. PMID: 14728992

8

Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy.

Karageorgos L, Harmatz P, Simon J, Pollard A, Clements PR, Brooks DA, Hopwood JJ. Karageorgos L, et al. Among authors: hopwood jj. Hum Mutat. 2004 Mar;23(3):229-33. doi: 10.1002/humu.10313. Hum Mutat. 2004. PMID: 14974081 Clinical Trial.

9

Immunoquantification of alpha-galactosidase: evaluation for the diagnosis of Fabry disease.

Fuller M, Lovejoy M, Brooks DA, Harkin ML, Hopwood JJ, Meikle PJ. Fuller M, et al. Among authors: hopwood jj. Clin Chem. 2004 Nov;50(11):1979-85. doi: 10.1373/clinchem.2004.037937. Epub 2004 Sep 13. Clin Chem. 2004. PMID: 15364892

10

Prediction of neuropathology in mucopolysaccharidosis I patients.

Fuller M, Brooks DA, Evangelista M, Hein LK, Hopwood JJ, Meikle PJ. Fuller M, et al. Among authors: hopwood jj. Mol Genet Metab. 2005 Jan;84(1):18-24. doi: 10.1016/j.ymgme.2004.09.004. Mol Genet Metab. 2005. PMID: 15639191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

408 results

Search Page